SCHEMBL10402416

SCHEMBL10402416

CCOC(=O)c1c(C)ccc(Cc2c[nH]cn2)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ JAK2 O60674 4/20 0.36
▸ JAK3 P52333 4/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ KDM5A P29375 1/20 0.36
▸ KDM5B Q9UGL1 1/20 0.36
▸ NR1H2 P55055 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9647525 0.85 P2RX3 (0.34) MAPTCYP3A4
SCHEMBL9646948 0.84 PKMYT1 (0.32) —
SCHEMBL10401559 0.83 CA12 (0.46) MAPTNPC1RAB9ALMNATP53
Hydrochloric Acid SCHEMBL10401596 0.82 PKMYT1 (0.31) —
SCHEMBL10402279 0.81 TSHR (0.44) MAPTLMNACA12CA1CA2
SCHEMBL10401616 0.78 CA12 (0.41) MAPTLMNACA12CA1CA2
SCHEMBL9646843 0.74 PRKCI (0.35) CA12CA1CA2CA7CA9
SCHEMBL9647120 0.73 PRKCI (0.34) —
Hydrochloric Acid SCHEMBL10402300 0.72 PRKCI (0.33) —
SCHEMBL10401974 0.70 ALDH1A1 (0.39) MAPTLMNAALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4923865-A Substituted 1-(1H-imidazol-4-yl)alkyl-benzamides as anti-ischemics and as alpha-2-adrenergic receptor agonists U C B SOCIETE ANONYME (BE) 1990-05-08 — — US disclosed
Send feedback